This is the new MLex platform. Existing customers should continue to use the existing MLex platform until migrated.
For any queries, please contact Customer Services or your Account Manager. Dismiss

Merck withdraws, plans to refile, Acceleron US merger paperwork on or about Nov. 1

( October 29, 2021, 22:31 GMT | Official Statement) -- MLex Summary: Merck withdrew and plans to refile the US antitrust paperwork on its acquisition of Acceleron on or about Nov. 1 in order to give the US Federal Trade Commission more time to review the deal, Merck said in a press release. The planned refile sets up an anticipated expiration of the waiting period on or about Nov. 16.Statement follows in full....

Prepare for tomorrow’s regulatory change, today

MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.


Know what others in the room don’t, with features including:

  • Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
  • Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
  • Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
  • Curated case files bringing together news, analysis and source documents in a single timeline

Experience MLex today with a 14-day free trial.

Start Free Trial

Already a subscriber? Click here to login